APA (7th ed.) Citation

VY, M., T, K., LE, S., HJ, K., M, P., AM, C., . . . JS, M. (2025). Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis. Clinical and translational science, 18(11), e70381. https://doi.org/10.1111/cts.70381

Chicago Style (17th ed.) Citation

VY, Muthukrishnan, Kerbusch T, Strong LE, Kleijn HJ, Pfister M, Chang AM, Acharya M, Nandy P, and McCune JS. "Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis." Clinical and Translational Science 18, no. 11 (2025): e70381. https://doi.org/10.1111/cts.70381.

MLA (9th ed.) Citation

VY, Muthukrishnan, et al. "Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis." Clinical and Translational Science, vol. 18, no. 11, 2025, p. e70381, https://doi.org/10.1111/cts.70381.